Subject(s)
BCG Vaccine , Mycobacterium bovis , Humans , BCG Vaccine/adverse effects , Infant , Male , Tuberculosis/diagnosisABSTRACT
OBJECTIVES: The aim of this study was to describe the evaluation of the use of MALDI-TOF MS for the identification of non-tuberculous mycobacteria (NTM) and Mycobacterium tuberculosis directly from liquid MGIT cultures from January 2017 to December 2017. MATERIAL/METHODS: A total of 155 isolates (mainly respiratory) were analyzed by MALDI-TOF MS (Bruker Daltonics) directly from MGIT liquid medium with a previous extraction procedure. RESULTS: MALDI-TOF MS generated acceptable scores for 152 isolates (98.06%). Fifty isolates were identified as M. tuberculosis complex and the remaining 105 as NTM (M. abscessus subsp. abscessus, M. avium, M. celatum, M chelonae, M. chimaera, M. fortuitum, M. gordonae, M. intracellulare, M. kansasii, M. lentiflavum, M. mageritense, M. mucogenicum and M. xenopi). CONCLUSIONS: These results indicate that MALDI-TOF MS can be useful to identify mycobacteria directly from MGIT cultures and is an accurate, rapid and cost-effective system to be used as a routine method.
Subject(s)
Mycobacterium tuberculosis , Nontuberculous Mycobacteria , Culture Media , Diagnostic Tests, Routine , Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSubject(s)
Tuberculoma/diagnosis , Tuberculosis, Cutaneous/diagnosis , Aged, 80 and over , Cicatrix/etiology , Delayed Diagnosis , Female , Giant Cells/ultrastructure , Histiocytes/ultrastructure , Humans , Lymphocytes/ultrastructure , Thigh , Treatment Refusal , Tuberculoma/microbiology , Tuberculoma/pathology , Tuberculosis, Cutaneous/microbiology , Tuberculosis, Cutaneous/pathologyABSTRACT
Tuberculosis is still a serious public health problem, with 10.8 million new cases and 1.8 million deaths worldwide in 2015. The diversity among members of the Mycobacterium tuberculosis complex, the causal agent of tuberculosis, is conducive to the design of different methods for rapid diagnosis. Mutations in the genes involved in resistance mechanisms enable the bacteria to elude the treatment. We have reviewed the methods for the rapid diagnosis of M. tuberculosis complex and the detection of susceptibility to drugs, both of which are necessary to prevent the onset of new resistance and to establish early, appropriate treatment.